Literature DB >> 36131041

Compartment-specific mutational landscape of clonal hematopoiesis.

Luise Hartmann1,2,3, Judith S Hecker2,3,4, Katharina S Götze5,6,7, Klaus H Metzeler8,9,10, Maja Rothenberg-Thurley1, Jennifer Rivière4, Madlen Jentzsch11, Bianka Ksienzyk1, Michèle C Buck4, Mark van der Garde2,3,4, Luise Fischer2,12, Susann Winter2,12, Martina Rauner2,13, Elena Tsourdi2,13, Heike Weidner2,13, Katja Sockel2,12, Marie Schneider2,11, Anne S Kubasch11, Martin Nolde14, Dominikus Hausmann14, Jörg Lützner15, Szymon Goralski16, Florian Bassermann3,4,17, Karsten Spiekermann1,2,3, Lorenz C Hofbauer2,3,13, Sebastian Schwind11, Uwe Platzbecker2,3,11.   

Abstract

Clonal hematopoiesis (CH) is characterized by somatic mutations in blood cells of individuals without hematologic disease. While the mutational landscape of CH in peripheral blood (PB) has been well characterized, detailed analyses addressing its spatial and cellular distribution in the bone marrow (BM) compartment are sparse. We studied CH driver mutations in healthy individuals (n = 261) across different anatomical and cellular compartments. Variant allele frequencies were higher in BM than PB and positively correlated with the number of driver variants, yet remained stable during a median of 12 months of follow-up. In CH carriers undergoing simultaneous bilateral hip replacement, we detected ASXL1-mutant clones in one anatomical location but not the contralateral side, indicating intra-patient spatial heterogeneity. Analyses of lineage involvement in ASXL1-mutated CH showed enriched clonality in BM stem and myeloid progenitor cells, while lymphocytes were particularly involved in individuals carrying the c.1934dupG variant, indicating different ASXL1 mutations may have distinct lineage distribution patterns. Patients with overt myeloid malignancies showed higher mutation numbers and allele frequencies and a shifting mutation landscape, notably characterized by increasing prevalence of DNMT3A codon R882 variants. Collectively, our data provide novel insights into the genetics, evolution, and spatial and lineage-specific BM involvement of CH.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 36131041     DOI: 10.1038/s41375-022-01700-3

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   12.883


  1 in total

Review 1.  Clonal hematopoiesis and nonhematologic disorders.

Authors:  Siddhartha Jaiswal
Journal:  Blood       Date:  2020-10-01       Impact factor: 25.476

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.